In our opinion, our results on ULK-1 expression in ErPCs isolated from sirolimus-treated patients are of interest since the role of ULK-1 in the pathophysiology of thalassemias is a topic of active interest [12] and translational applications [38]. The gene discussed is ULK1; the disease is thalassemia.